Murine and human hematopoietic progenitor cultures grown on stromal layers expressing Notch ligands
- Authors: Raevskaya A.A.1, Savvateeva M.V.1, Bukhinnik S.S.1, Kandarakov O.F.1, Butylin P.A.2, Zhuk S.V.2, Demin A.M.3, Krasnov V.P.3, Zaritsky A.Y.2, Belyavsky A.V.1
-
Affiliations:
- Engelhardt Institute of Molecular Biology
- Almazov Federal North-West Medical Research Center
- Postovsky Institute of Organic Synthesis
- Issue: Vol 51, No 2 (2017)
- Pages: 313-322
- Section: Molecular Cell Biology
- URL: https://journal-vniispk.ru/0026-8933/article/view/163044
- DOI: https://doi.org/10.1134/S0026893317020169
- ID: 163044
Cite item
Abstract
The ex vivo maintenance and expansion of hematopoietic stem cells and early progenitors is necessary for the successful treatment of hematopoietic and immune diseases. Multiple attempts to improve the expansion of hematopoietic stem cells (HSCs) by their cultivation in the presence of growth factor cocktails have so far failed. Novel approaches aimed at conserving the earliest precursors in their undifferentiated state are needed. These approaches should take into account local regulatory factors that are present in the HSC microenvironment and the three-dimensional architecture of their niche. In the present study, we compared the effects of two Notch ligands, i.e., Jagged1 and DLL1, on murine and human hematopoiesis in vitro. Our observations indicate that the stromal expression of Notch ligands increases the production of both the total and phenotypically early murine and human hematopoietic cells in the co-culture. On one hand, this study demonstrates the similarity of effects of stromal expression of Notch ligands on murine and human hematopoiesis in vitro. On the other hand, our study revealed a number of cell type and ligand-specific variations that are systematically described below. It seems that the effects of SCF cytokine addition on murine hematopoiesis in vitro depend on the stromal context and are oppositely directed for Jagged1 and DLL1.
About the authors
A. A. Raevskaya
Engelhardt Institute of Molecular Biology
Email: abelyavs@yahoo.com
Russian Federation, Moscow, 119991
M. V. Savvateeva
Engelhardt Institute of Molecular Biology
Email: abelyavs@yahoo.com
Russian Federation, Moscow, 119991
S. S. Bukhinnik
Engelhardt Institute of Molecular Biology
Email: abelyavs@yahoo.com
Russian Federation, Moscow, 119991
O. F. Kandarakov
Engelhardt Institute of Molecular Biology
Email: abelyavs@yahoo.com
Russian Federation, Moscow, 119991
P. A. Butylin
Almazov Federal North-West Medical Research Center
Email: abelyavs@yahoo.com
Russian Federation, St. Petersburg, 197341
S. V. Zhuk
Almazov Federal North-West Medical Research Center
Email: abelyavs@yahoo.com
Russian Federation, St. Petersburg, 197341
A. M. Demin
Postovsky Institute of Organic Synthesis
Email: abelyavs@yahoo.com
Russian Federation, Yekaterinburg, 620990
V. P. Krasnov
Postovsky Institute of Organic Synthesis
Email: abelyavs@yahoo.com
Russian Federation, Yekaterinburg, 620990
A. Y. Zaritsky
Almazov Federal North-West Medical Research Center
Email: abelyavs@yahoo.com
Russian Federation, St. Petersburg, 197341
A. V. Belyavsky
Engelhardt Institute of Molecular Biology
Author for correspondence.
Email: abelyavs@yahoo.com
Russian Federation, Moscow, 119991
Supplementary files
